Virtus Investment Advisers »

Adma Biologics shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $711k 157k 4.52
2023-09-30 $261k 73k 3.58
2023-06-30 $223k 60k 3.69

More positions owned by Virtus Investment Advisers

Pimco Etf Tr Enhancd Short (EMNT)
Virtus Etf Tr Ii Duff & Phelps Cl (VCLN)
Vipshop Hldgs Sponsored Ads A (VIPS)
Icici Bank Adr (IBN)
Coca-Cola Bottling Co. Consolidated (COKE)
Apple (AAPL)
Microsoft Corporation (MSFT)
Warrior Met Coal (HCC)
Boise Cascade (BCC)
NVIDIA Corporation (NVDA)
Barrett Business Services (BBSI)
Rush Enterprises Cl A (RUSHA)
Gulfport Energy Corp Common Shares (GPOR)
Janus International Group In Common Stock (JBI)
Prestige Brands Holdings (PBH)

View all positions for Virtus Investment Advisers

Top funds holding Adma Biologics

Vanguard Group
D. E. Shaw & Co
Perceptive Advisors
AWM Investment Company
Dimensional Fund Advisors
Millennium Management
Assenagon Asset Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Oberweis Asset Management
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Tang Capital Management

View all funds holding Adma Biologics